Abstract
The human MAS-related G protein–coupled receptor X1 (MRGPRX1) is preferentially expressed in the small-diameter primary sensory neurons and involved in the mediation of nociception and pruritus. Central activation of MRGPRX1 by the endogenous opioid peptide fragment BAM8-22 and its positive allosteric modulator ML382 has been shown to effectively inhibit persistent pain, making MRGPRX1 a promising target for non-opioid pain treatment. However, the activation mechanism of MRGPRX1 is still largely unknown. Here we report three high-resolution cryogenic electron microscopy structures of MRGPRX1–Gαq in complex with BAM8-22 alone, with BAM8-22 and ML382 simultaneously as well as with a synthetic agonist compound-16. These structures reveal the agonist binding mode for MRGPRX1 and illuminate the structural requirements for positive allosteric modulation. Collectively, our findings provide a molecular understanding of the activation and allosteric modulation of the MRGPRX1 receptor, which could facilitate the structure-based design of non-opioid pain-relieving drugs.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The coordinate and cryo-EM map of MRGPRX1–Gq–BAM8-22, MRGPRX1–Gq–BAM8-22/ML382 and MRGPRX1–Gq–compound-16 have been deposited to the Protein Data Bank (Electron Microscopy Data Bank) database with accession codes 8DWC (EMD-27752), 8DWG (EMD-27753) and 8DWH (EMD-27754), respectively. The cryo-EM micrographs of MRGPRX1–Gq–BAM8-22, MRGPRX1–Gq–BAM8-22/ML382 and MRGPRX1–Gq–compound-16 have been deposited in the EMPIAR database (https://www.ebi.ac.uk/empiar/) with accession numbers EMPIAR-11183, EMPIAR-11188 and EMPIAR-11191, respectively. Source data are provided with this paper.
References
St Sauver, J. L. et al. Why patients visit their doctors: assessing the most prevalent conditions in a defined American population. Mayo Clin. Proc. 88, 56–67 (2013).
Sharif, B., Ase, A. R., Ribeiro-da-Silva, A. & Seguela, P. Differential coding of itch and pain by a subpopulation of primary afferent neurons. Neuron 106, 940–951 (2020).
Racine, M., Hudson, M., Baron, M., Nielson, W. R. & Canadian Scleroderma Research, G. The impact of pain and itch on functioning and health-related quality of life in systemic sclerosis: an exploratory study. J. Pain. Symptom Manag. 52, 43–53 (2016).
Klein, A. et al. Pruriception and neuronal coding in nociceptor subtypes in human and nonhuman primates. eLife 10, e64506 (2021).
Sun, S. et al. Leaky gate model: intensity-dependent coding of pain and itch in the spinal cord. Neuron 93, 840–853 (2017).
Shim, W. S. & Oh, U. Histamine-induced itch and its relationship with pain. Mol. Pain. 4, 29 (2008).
Meixiong, J. & Dong, X. Mas-related G protein–coupled receptors and the biology of itch sensation. Annu. Rev. Genet. 51, 103–121 (2017).
Akiyama, T., Lerner, E. A. & Carstens, E. Protease-activated receptors and itch. Handb. Exp. Pharmacol. 226, 219–235 (2015).
Feng, J. et al. Piezo2 channel–Merkel cell signaling modulates the conversion of touch to itch. Science 360, 530–533 (2018).
Dong, X., Han, S., Zylka, M. J., Simon, M. I. & Anderson, D. J. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 106, 619–632 (2001).
Liu, Q. et al. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 139, 1353–1365 (2009).
Li, Z. et al. Targeting human Mas-related G protein–coupled receptor X1 to inhibit persistent pain. Proc. Natl Acad. Sci. USA 114, E1996–E2005 (2017).
Lembo, P. M. et al. Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat. Neurosci. 5, 201–209 (2002).
Wen, W. et al. Discovery and characterization of 2-(cyclopropanesulfonamido)-N-(2-ethoxyphenyl)benzamide, ML382: a potent and selective positive allosteric modulator of MrgX1. ChemMedChem 10, 57–61 (2015).
Tseng, P. Y., Zheng, Q., Li, Z. & Dong, X. MrgprX1 mediates neuronal excitability and itch through tetrodotoxin-resistant sodium channels. Itch (Phila) 4, e28 (2019).
Cao, C. et al. Structure, function and pharmacology of human itch GPCRs. Nature 600, 170–175 (2021).
Prchalová, E. et al. Discovery of benzamidine- and 1-aminoisoquinoline-based human MAS-related G-protein-coupled receptor X1 (MRGPRX1) agonists. J. Med. Chem. 62, 8631–8641 (2019).
Kim, K. et al. Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor. Cell 182, 1574–1588 (2020).
Koehl, A. et al. Structure of the µ-opioid receptor–Gi protein complex. Nature 558, 547–552 (2018).
Ballesteros, J. A. & Weinstein, H. in Methods in Neurosciences Vol. 25 (ed Sealfon, S. C.) 366–428 (Academic Press, 1995).
Han, S. K. et al. Orphan G protein-coupled receptors MrgA1 and MrgC11 are distinctively activated by RF-amide-related peptides through the Gαq/11 pathway. Proc. Natl Acad. Sci. USA 99, 14740–14745 (2002).
Olsen, R. H. J. et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat. Chem. Biol. 16, 841–849 (2020).
Kruse, A. C. et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature 504, 101–106 (2013).
Wold, E. A., Chen, J., Cunningham, K. A. & Zhou, J. Allosteric modulation of class A GPCRs: targets, agents, and emerging concepts. J. Med. Chem. 62, 88–127 (2019).
Lu, J. et al. Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40. Nat. Struct. Mol. Biol. 24, 570–577 (2017).
Zhuang, Y. et al. Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor. Cell Res. 31, 593–596 (2021).
Karhu, T. et al. Isolation of new ligands for orphan receptor MRGPRX1—hemorphins LVV-H7 and VV-H7. Peptides 96, 61–66 (2017).
Li, X. et al. Tick peptides evoke itch by activating MrgprC11/MRGPRX1 to sensitize TRPV1 in pruriceptors. J. Allergy Clin. Immunol. 147, 2236–2248 (2021).
Du, Y. et al. Assembly of a GPCR-G protein complex. Cell 177, 1232–1242 (2019).
Xu, P. et al. Structural insights into the lipid and ligand regulation of serotonin receptors. Nature 592, 469–473 (2021).
Peck, J. V., Fay, J. F. & Strauss, J. D. High-speed high-resolution data collection on a 200 keV cryo-TEM. IUCrJ 9, 243–252 (2022).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214–1221 (2020).
Rosenthal, P. B. & Henderson, R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 333, 721–745 (2003).
Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 4, 874 (2021).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
Robertson, M. J., van Zundert, G. C. P., Borrelli, K. & Skiniotis, G. GemSpot: a pipeline for robust modeling of ligands into cryo-EM maps. Structure 28, 707–716 (2020).
Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12–21 (2010).
Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021).
Pryce, K. D. et al. A promising chemical series of positive allosteric modulators of the mu-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects. Neuropharmacology 195, 108673 (2021).
Sadybekov, A. A. et al. Synthon-based ligand discovery in virtual libraries of over 11 billion compounds. Nature 601, 452–459 (2022).
Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320–324 (2014).
Acknowledgements
This work was supported by National Institutes of Health grants R01DA055656 and U24DK116195 to B.L.R. and B.K.S. as well as the Michael Hooker Distinguished Professorship to B.L.R. We thank J. Peck and J. Strauss of the University of North Carolina Cryo-EM Core Facility for their technical assistance with this project.
Author information
Authors and Affiliations
Contributions
Y.L. designed the experiments, generated the MRGPRX1 constructs for Sf9 insect cell expression, expressed and purified the MRGPRX1 signaling complexes for cryo-EM study, performed the BRET assays, analyzed the data, prepared the figures and tables and assisted in manuscript preparation. C.C. designed the experiments, assisted in the protein purification, built the models, refined the structures, analyzed the data and prepared the figures and the manuscript. J.F. prepared the cryo-EM grids, collected the cryo-EM data and performed the cryo-EM map calculation. R.H.G. and M.M.R. assisted in the validation of structures. X.-P.H. and Y.L. performed the GPCRome assays. S.-L.S. and Y.L. generated the MRGPRX1 mutations for functional assays. B.E.K designed the mini-Gαq protein construct and assisted in the functional data analysis. S.Z. assisted in the protein expression. B.K.S. provided valuable insights and edited the manuscript. B.L.R. supervised the overall project and edited the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Chemical Biology thanks Corey Hopkins and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Extended cryo-EM analysis of the MRGPRX1-Gq complex bound to BAM8-22, BAM8-22/ML382, and compound-16, respectively.
a, Representative cryo-EM micrograph (scale bar: 100 nm) of the MRGPRX1-Gq-BAM8-22, MRGPRX1-Gq-BAM8-22/ML382 and MRGPRX1-Gq-comppound-16 complexes. The exact number of movies and particles used for each complex are shown in Supplementary Fig. 2. The experiment was repeated three times with similar result. b, Histograms of defocus values for micrographs used in the single particle analysis (see Supplementary Table 4 for more details). c, Orientational distribution heat map. d, 2D plots of the gold standard Fourier shell correlation (GSFSC) between half maps (black) and FSC between model and the B-factor sharpened map for respective refined model (red) as calculated by phenix.mtirage. e, Local resolution heat-map calculated using the local windowed FSC method.
Extended Data Fig. 2 Electron microscopy density map of MRGPRX1-Gq-BAM8-22, MRGPRX1-Gq-BAM8-22/ML382, and MRGPRX1-Gq-compound-16 complexes.
a-c, EM density of the ligand, TM1-TM7 helices of MRGPRX1 and the α5 and αN helices of Gq of MRGPRX1-Gq-BAM8-22 (a), MRGPRX1-Gq-BAM8-22/ML382 (b) and MRGPRX1-Gq-compound-16 (c), respectively.
Extended Data Fig. 3 Comparison of MRGPRX1 PAM binding site with other GPCRs.
a-d, The binding modes of agonist and PAM of MRGPRX1 (a), M2R (PDB ID: 4MQT) (b), GPR40 (PDB ID: 5TZY) (c) and DRD1 (PDB ID: 7LJD) (d). The peptide agonist is shown as cartoon. Small molecule orthosteric agonists and PAMs are shown as sticks. Orthosteric agonist and PAM are colored by bule and yellow, respectively.
Extended Data Fig. 4 Mutations of MRGPRX1 allosteric site residues affect ML382 allosteric properties.
a-l, Representative Gq BRET2 dose–response curves of WT and mutations of key residues of MRGPRX1 in the presence of indicated concentration of the allosteric modulator ML382. Data are mean ± SEM of n = 3 biological replicates.
Extended Data Fig. 5 Structural comparison of the MRGPRX1-Gq-BAM8-22 complex with MRGPRX1-Gq-BAM8-22/ML382 complex.
a-c, The overall alignment of the MRGPRX1-Gq-BAM8-22 complex with MRGPRX1-Gq-BAM8-22/ML382 complex. Side-view to show the overall complexes (a). Extracellular view to show the overall similar peptide binding mode (b). Intracellular view to show the α5 binding pocket (c). d, Cross-section image to show the binding of BAM8-22 and ML382 in MRGPRX1. e, Cross-section image to show the binding of BAM8-22 alone in MRGPRX1.
Extended Data Fig. 6 Selectivity of compound-16 and ML382 among other GPCRs.
a-b, Screening of ML382 (a) and compound-16 (b) in single concentration (10 µM) at 318 receptors in PRESTO-Tango GPCRome assays. Dopamine (D2) with 100 nM quinpirole was used as the assay control (assay ctrl). The data are plotted as fold of basal activity and presented as mean ± SEM (n = 4). The ones with >3-fold of basal were took as pronounced hits. c-h, Follow-up dose response curves for the targets with > 3-fold increased activity. Known agonist for each receptor was used as positive controls, and all the results were normalized to these controls (c-g). For MRGPRX1, the results were plotted as fold of basal (g-h). All the data are presented as mean ± SEM of n = 3 independent experiments.
Extended Data Fig. 7 Structural comparison of MRGPRX1-Gq-compound-16 complex with MRGPRX1-Gq-BAM8-22/ML382 complex.
a, The orthosteric pocket for compound-16 (cyan) is larger than that of BAM8-22 (green). b-c, Structural superposition of MRGPRX1-Gq-compound-16 complex and MRGPRX1-Gq-BAM8-22/ML382 to show compound-16 has a weak contact with the allosteric modulator ML382. Side view (b). Top view (c). d, ML382 displays very weak PAM activity at compound-16 in BRET2 Gq activation assay. Data are mean ± SEM of n = 4 biological replicates.
Extended Data Fig. 8 Residue compositions of the extracellular and intracellular pockets of MRGPRX family receptors.
a, Structure of MRGPRX1 with the resides conserved in MRGPRX1, MRGPRX2 (PDB: 7S8N) and MRGPRX4 (PDB: 7S8P) colored in red. Figure is generated by ENDscript45. b-d, Residue compositions of the orthosteric pocket (b), allosteric pocket (c) and G protein interface (d) of the MRGPRX family receptors. The pocket residues are selected based on the MRGPRX1-Gq-BAM8-22/ML382 structure. The conserved residues are highlighted in green.
Extended Data Fig. 9 The G protein interface of MRGPRX1.
a, key interactions between the intracellular cavity of MRGPRX1 (green) and the α5 helix of Gq (red). The structure of MRGPRX1-Gq-BAM8-22/ML382 complex is used for structural analysis. b, Key interactions between the ICL2 of MRGPRX1 and the G protein. c-e, BRET2 validation of the intracellular cavity mutations of MRGPRX1 in presence of compound-16 (c), BAM8-22 alone (d) and BAM8-22 with 1 µM ML382 (e). f-h, BRET2 validation of the ICL2 mutations of MRGPRX1 in presence of compound-16 (f), BAM8-22 alone (g) and BAM8-22 with 1 µM ML382 (h). Data are mean ± SEM of n = 4 biological replicates.
Supplementary information
Supplementary Information
Supplementary Figs. 1–8, Supplementary Tables 1–5 and unprocessed scan of gels
Supplementary Table 1
Source data related to Supplementary Fig. 1
Supplementary Table 2
Source data related to Supplementary Fig. 4
Supplementary Table 3
Source data related to Supplementary Fig. 5
Supplementary Table 4
Source data related to Supplementary Fig. 6
Supplementary Table 5
Source data related to Supplementary Fig. 8
Source data
Source Data Fig. 2
Statistical Source Data
Source Data Fig. 3
Statistical Source Data
Source Data Fig. 4
Statistical Source Data
Source Data Extended Data Fig. 4
Statistical Source Data
Source Data Extended Data Fig. 6
Statistical Source Data
Source Data Extended Data Fig. 7
Statistical Source Data
Source Data Extended Data Fig. 9
Statistical Source Data
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, Y., Cao, C., Huang, XP. et al. Ligand recognition and allosteric modulation of the human MRGPRX1 receptor. Nat Chem Biol 19, 416–422 (2023). https://doi.org/10.1038/s41589-022-01173-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-022-01173-6
This article is cited by
-
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Signal Transduction and Targeted Therapy (2024)
-
Pathology of pain and its implications for therapeutic interventions
Signal Transduction and Targeted Therapy (2024)
-
A large expert-curated cryo-EM image dataset for machine learning protein particle picking
Scientific Data (2023)
-
Orthosteric and allosteric modulation of human HCAR2 signaling complex
Nature Communications (2023)
-
Ligand recognition and G protein coupling of the human itch receptor MRGPRX1
Nature Communications (2023)